Our results were partly in line with recent studies that revealed an inverse relationship between BMI and the RS in postmenopausal women with hormone receptor-positive, HER2-negative breast cancer (23), and a higher proportion of RS <11 in obese patients compared with non-overweight breast cancer patients (24). The gene discussed is ERBB2; the disease is breast carcinoma.